These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 15012621)

  • 21. Comparison of finasteride and flutamide in the treatment of idiopathic hirsutism.
    Falsetti L; Gambera A
    Fertil Steril; 1999 Jul; 72(1):41-6. PubMed ID: 10428146
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of Diane 35 and Diane 35 plus spironolactone in the treatment of hirsutism.
    Keleştimur F; Sahin Y
    Fertil Steril; 1998 Jan; 69(1):66-9. PubMed ID: 9457935
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New alternative treatment in hirsutism: bicalutamide 25 mg/day.
    Müderris II; Bayram F; Ozçelik B; Güven M
    Gynecol Endocrinol; 2002 Feb; 16(1):63-6. PubMed ID: 11915584
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the efficiency of anti-androgenic regimens consisting of spironolactone, Diane 35, and cyproterone acetate in hirsutism.
    Sert M; Tetiker T; Kirim S
    Acta Med Okayama; 2003 Apr; 57(2):73-6. PubMed ID: 12866746
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical and endocrine effects of finasteride, a 5 alpha-reductase inhibitor, in women with idiopathic hirsutism.
    Ciotta L; Cianci A; Calogero AE; Palumbo MA; Marletta E; Sciuto A; Palumbo G
    Fertil Steril; 1995 Aug; 64(2):299-306. PubMed ID: 7615107
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Finasteride versus cyproterone acetate-estrogen regimens in the treatment of hirsutism.
    Beigi A; Sobhi A; Zarrinkoub F
    Int J Gynaecol Obstet; 2004 Oct; 87(1):29-33. PubMed ID: 15464773
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hirsutism--a low dose spironolactone therapy.
    Vĕtr M
    Acta Univ Palacki Olomuc Fac Med; 1989; 122():239-45. PubMed ID: 2530821
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical and hormonal effects of the 5 alpha-reductase inhibitor finasteride in idiopathic hirsutism.
    Moghetti P; Castello R; Magnani CM; Tosi F; Negri C; Armanini D; Bellotti G; Muggeo M
    J Clin Endocrinol Metab; 1994 Oct; 79(4):1115-21. PubMed ID: 7962284
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of finasteride in idiopathic hirsutism.
    Faloia E; Filipponi S; Mancini V; Di Marco S; Mantero F
    J Endocrinol Invest; 1998 Nov; 21(10):694-8. PubMed ID: 9854686
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hirsutism: metabolic effects of two commonly used oral contraceptives and spironolactone.
    Wild RA; Demers LM; Applebaum-Bowden D; Lenker R
    Contraception; 1991 Aug; 44(2):113-24. PubMed ID: 1893706
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of spironolactone and spironolactone plus finasteride in the treatment of hirsutism.
    Unlühizarci K K; Everest H; Bayram F; Keleştimur F
    Fertil Steril; 2002 Dec; 78(6):1331-3. PubMed ID: 12477537
    [No Abstract]   [Full Text] [Related]  

  • 32. Comparison of finasteride versus flutamide in the treatment of hirsutism.
    Falsetti L; Gambera A; Legrenzi L; Iacobello C; Bugari G
    Eur J Endocrinol; 1999 Oct; 141(4):361-7. PubMed ID: 10526249
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of the clinical efficacy of flutamide and spironolactone plus ethinyloestradiol/cyproterone acetate in the treatment of hirsutism: a randomised controlled study.
    Karakurt F; Sahin I; Güler S; Demirbas B; Culha C; Serter R; Aral Y; Bavbek N
    Adv Ther; 2008 Apr; 25(4):321-8. PubMed ID: 18389188
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of flutamide and spironolactone in the treatment of hirsutism: a randomized controlled trial.
    Cusan L; Dupont A; Gomez JL; Tremblay RR; Labrie F
    Fertil Steril; 1994 Feb; 61(2):281-7. PubMed ID: 8299783
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiandrogenic properties of spironolactone. Clinical trial in the management of female hirsutism.
    Messina M; Manieri C; Biffignandi P; Massucchetti C; Novi RF; Molinatti GM
    J Endocrinol Invest; 1983 Feb; 6(1):23-7. PubMed ID: 6404979
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of four different treatment regimes in hirsutism related to polycystic ovary syndrome.
    Gökmen O; Senöz S; Gülekli B; Işik AZ
    Gynecol Endocrinol; 1996 Aug; 10(4):249-55. PubMed ID: 8908525
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparison between finasteride, flutamide, and finasteride plus flutamide combination in the treatment of hirsutism.
    Unluhizarci K; Ozel D; Tanriverdi F; Karaca Z; Kelestimur F
    J Endocrinol Invest; 2009 Jan; 32(1):37-40. PubMed ID: 19337013
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A prospective randomized trial comparing low dose flutamide, finasteride, ketoconazole, and cyproterone acetate-estrogen regimens in the treatment of hirsutism.
    Venturoli S; Marescalchi O; Colombo FM; Macrelli S; Ravaioli B; Bagnoli A; Paradisi R; Flamigni C
    J Clin Endocrinol Metab; 1999 Apr; 84(4):1304-10. PubMed ID: 10199771
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low-dose (2.5 mg/day) finasteride treatment in hirsutism.
    Bayram F; Müderris I; Güven M; Ozçelik B; Keleştimur F
    Gynecol Endocrinol; 2003 Oct; 17(5):419-22. PubMed ID: 14710591
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Spironolactone in the treatment of hirsutism.
    Anttila L; Ruutiainen K; Erkkola R
    Ann Chir Gynaecol Suppl; 1987; 202():32-4. PubMed ID: 3310825
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.